A (ECS 2000-2009)

ABHD6 / a / B-hydrolase Domain 6 (Breaks Down 2-AG)
2-AG / 2-ARACHIDONOYLGLYCEROL (CB1 Agonist)
2-AGE / 2-ARACHIDONYL GLYCERYL ETHER / NOLADIN ETHER (CB1 Antagonist, CB2 Agonist)
ANANDAMIDE / AEA / N-ARACHIDONOYLETHANOLAMINE (CB1 and 2 Agonist)


ABHD6 / a / B-hydrolase Domain 6
Activation of the endocannabinoid system by organophosphorus nerve agents (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597283/
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarizationinduced suppression of excitation in autaptic hippocampal neurons (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784730/
High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1349-7006.2009.01347.x/full


2-AG / 2-ARACHIDONOYLGLYCEROL
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
Synthesis and Biological Activities of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, and Its Metabolically Stable Ether-linked Analogues (full–2000) http://cpb.pharm.or.jp/cpb/200007/C07_0903.pdf
Endocannabinoids control spasticity in a multiple sclerosis model (full-2000) http://www.fasebj.org/cgi/reprint/00-0399fjev1?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=HWCIT
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide (full–2000) http://molpharm.aspetjournals.org/content/57/5/1045.long
Endocannabinoids and Vascular Function (full-2000) http://jpet.aspetjournals.org/content/294/1/27.long
Endogenous cannabinoids and appetite (full–2000) http://journals.cambridge.org/download.php?file=%2FNRR%2FNRR14_01%2FS095442240100004Xa.pdf&code=840ac1e121b1a8563a840b894cced959
2-Arachidonoylglycerol and the cannabinoid receptors (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11106784
Cardiovascular effects of endocannabinoids–the plot thickens (abst-2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=10785543&dopt=abstractplus
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11106791
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11011050
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572991/?tool=pubmed
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full-2001) http://content.onlinejacc.org/cgi/content/full/38/7/2048?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT
Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors (full-2001) http://jpet.aspetjournals.org/content/299/3/951.full
Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572744/
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31108/
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts (full–2001) http://cardiovascres.oxfordjournals.org/content/55/3/619.full?sid=750cba66-d3d1-484d-96e8-04975ba34325
The neurobiology and evolution of cannabinoid signalling (full-2001) http://rstb.royalsocietypublishing.org/content/356/1407/381.full.pdf+html
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572991/
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury (abst-2001) http://www.ncbi.nlm.nih.gov/pubmed/11586361
Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors,
Vanilloid Receptors, and Anandamide (full–2002) http://www.cannabis-med.org/data/pdf/2002-01-3.pdf
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells (full-2002) http://www.fasebj.org/cgi/content/full/15/12/2171?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=HWCIT
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol)
are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids (full–2002) http://jpet.aspetjournals.org/content/300/1/34.long
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid (full–2002) http://www.iovs.org/content/43/10/3216.full
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol (full–2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573386/?tool=pubmed
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12393235
Endocannabinoids and related fatty acid derivatives in pain modulation (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Endocannabinoids in the central nervous system-an overview (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12052038
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12395075
Endocannabinoids in the immune system and cancer (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12052046
The quest for a vascular endothelial cannabinoid receptor (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505689
Endocannabinoids protect the rat isolated heart against ischaemia (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573907/?tool=pmcentrez
Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl
Glycerol, in Rat Brain (full-2003) http://www.nature.com/npp/journal/v28/n6/full/1300117a.html
Role of Endogenous Cannabinoids in Synaptic Signaling (full-2003) http://physrev.physiology.org/cgi/content/full/83/3/1017?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy (full-2003) http://jpet.aspetjournals.org/content/307/1/129.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
Manipulation of the endocannabinoid system by a general anaesthetic (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573927/?tool=pubmed
Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716 (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12447606
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12914975
The endocannabinoid system: a general view and latest additions (full-2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574255/?tool=pmcentrez
The endocannabinoid system: physiology and pharmacology (full-2004) http://alcalc.oxfordjournals.org/cgi/content/full/40/1/2
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation (full-2004) https://www.jstage.jst.go.jp/article/jphs/96/4/96_4_367/_pdf
2-Arachidonoylglycerol A Novel Inhibitor of Androgen-Independent Prostate Cancer Cell Invasion (full-2004) http://cancerres.aacrjournals.org/cgi/content/full/64/24/8826?ijkey=951f5f9d238bdf059cf30ee2be3a 5a31aaf2b094
Endogenous Cannabinoids Take the Edge off Neuroendocrine Responses to Stress (full–2004) http://press.endocrine.org/doi/full/10.1210/en.2004-1218
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/15159678
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14676677
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1450257/
Role of the endocannabinoid system in the development of tolerance to alcohol (full–2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1134878/
Analgesia through endogenous cannabinoids (full-2005) http://www.cmaj.ca/cgi/content/full/173/4/357?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=endocannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
Cannabinoids and cancer: potential for colorectal cancer therapy (full-2005) http://www.biochemsoctrans.org/bst/033/0712/bst0330712.htm
CB1 cannabinoid receptor-mediated modulation of food intake in mice (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576140/?tool=pmcentrez
Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs (full–2005) https://www.jstage.jst.go.jp/article/jnms/72/1/72_1_43/_pdf
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders (full–2005) http://www.jleukbio.org/content/78/1/231.long
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob)
mice and implications for fertility (full–2005) http://molehr.oxfordjournals.org/content/11/1/21.full
Finding of endocannabinoids in human eye tissues: implications for glaucoma (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15823551
Cannabinoids and the digestive tract (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16596788
Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic
brain tissue and inhibition by putative endocannabinoids (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15923084
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
Waterborne lead exposure affects brain endocannabinoid content in male but not female fathead minnows (Pimephales promelas) (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15527869
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15921709
Body’s Own Marijuana-Like Compounds Are Crucial For Stress-Induced Pain Relief (news-2005) http://www.sciencedaily.com/releases/2005/06/050628064435.htm
Natural Cannabinoids Blunt Pain (news-2005) http://www.drugfree.org/join-together/drugs/natural-cannabinoids-blunt
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and
ß-Pancreatic Cells and in Obesity and Hyperglycemia (full-2006) http://press.endocrine.org/doi/full/10.1210/jc.2005-2679?view=long&pmid=16684820
Endocannabinoids, feeding and suckling – from our perspective (full–2006) http://www.nature.com/ijo/journal/v30/n1s/full/0803274a.html
Not Too Excited? Thank Your Endocannabinoids (full-2006) http://www.sciencedirect.com/science/article/pii/S0896627306005927
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458883/?tool=pmcentrez
Weight Control in Individuals With Diabetes (full-2006) http://care.diabetesjournals.org/content/29/12/2749.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=2000&resourcetype=HWCIT
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation (full–2006) http://www.fasebj.org/content/early/2004/10/02/fj.04-1754fje.long
Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice (full–2006) http://www.jimmunol.org/content/177/12/8796.full
Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal
functions (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16506408
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16732431
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16949718
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation
of brain 2-arachidonoylglycerol and the associated hypomotility in mice (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16310817
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous
cannabinoid receptor ligand (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16678907
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16364651
Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16787257
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis (full-2007) http://www.jbc.org/content/282/33/23892.full
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692834/
Endocannabinoids and the haematological system (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755791/?tool=pmcentrez
Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565646/?tool=pubmed
Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth : RECRUITMENT OF Fas AND Fas LIGAND TO LIPID RAFTS (full–2007) http://www.jbc.org/content/282/17/13098.full
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042935/?tool=pubmed
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez
Endocannabinoids block status epilepticus in cultured hippocampal neurons (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2617750/?tool=pmcentrez
Chronologically overlapping occurrences of nicotine-induced anxiety- and depression related behavioral symptoms: effects of anxiolytic and cannabinoid drugs (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075518/?tool=pubmed
2-AG + 2 new players = forecast for therapeutic advances (full–2007) http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRP-4RFCCVN-4&_user=10&_coverDate=12%2F26%2F2007&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=9eef728e35c89b5764ef2d27c0cdffe9&searchtype=a
CB2 receptors in the brain: role in central immune function (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez
Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth (full-2007) http://www.jbc.org/content/282/17/13098.full
n-3 Fatty acids and the endocannabinoid system (letter–2007) http://ajcn.nutrition.org/content/85/3/919.1.long
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher (interview-2007) http://www.jleukbio.org/cgi/content/full/82/6/1390?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT
In Vitro Anticonvulsant Action of 2-Arachidonyl Glycerol (abst–2007) http://jkaumedsci.sa/kau/index.php/jkaumedsci/article/view/165
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17419758
The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17706636
The Endocannabinoids: Functional Roles and Therapeutic Opportunities (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11344&CultureCode=en
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling (full-2008) http://www.fasebj.org/cgi/content/full/22/1/285
Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells (full-2008) http://www.jimmunol.org/cgi/content/full/181/9/6406?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
Activation of the endocannabinoid system by organophosphorus nerve agents (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597283/
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling (full–2008) http://www.fasebj.org/content/22/10/3685.long
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages (full–2008) http://cardiovascres.oxfordjournals.org/content/81/4/805.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation (full–2008) http://www.jbc.org/content/283/33/22601.full
Endocannabinoids and nutrition (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full
Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in Rats (full-2008) http://www.jneurosci.org/cgi/content/full/28/39/9702?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Cannabinoid receptors and the regulation of bone mass (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219540/?tool=pmcentrez
Role of endocannabinoids in cardiovascular shock (full–2008) http://www.jpp.krakow.pl/journal/archive/12_08_s8/pdf/91_12_08_s8_article.pdf
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin Induced Cardiotoxicity (full-2008) http://content.onlinejacc.org/cgi/content/full/50/6/528
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full-2008) http://onlinelibrary.wiley.com/doi/10.1038/oby.2007.106/pdf
Endocannabinoids and the Control of Energy Homeostasis (full–2008) http://www.jbc.org/content/283/48/33021.full?sid=931583b1-e797-43e0-8296-7fd75bb49403
The influence of mast cell mediators on migration of SW756 cervical carcinoma cells (full–2008) https://www.jstage.jst.go.jp/article/jphs/106/2/106_FP0070736/_pdf
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755791/?tool=pubmed
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system (full–2008) http://onlinelibrary.wiley.com/doi/10.1002/dneu.20666/pdf
Mechanisms for Recycling and Biosynthesis of Endogenous Cannabinoids Anandamide and 2-Arachidonylglycerol (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581634/?tool=pmcentrez
Endocannabinoids in the retina: from marijuana to neuroprotection (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584875/
Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01684.x/full
Dysregulation of the endocannabinoid system in obesity (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01683.x/full
Endogenous cannabinoids: structure and metabolism (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01676.x/full
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18343566
The role of the CB1 receptor in the regulation of sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Cat odour-induced anxiety–a study of the involvement of the endocannabinoid system (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/17882402
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18535023
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18204441
Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol
lipase inhibitors (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18289091
Cox–2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells through generation of prostaglandingycerol esters (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2008-1037457
Understanding the effects of endogenous cannabinoids (news-2008) http://arstechnica.com/science/news/2008/11/understanding-the-effects-of-endogenous-cannabinoids.ars
Marijuana-Inspired Painkiller? New Chemical Pathway Discovered (news-2008) http://www.sciencedaily.com/releases/2008/11/081123150249.htm
LSUHSC research reports new method to protect brain cells from diseases like Alzheimer’s (news–2008) http://www.eurekalert.org/pub_releases/2008-08/lsuh-lrr082008.php
Understanding the Effects of Endogenous Cannabinoids (news–2008) http://arstechnica.com/science/2008/11/understanding-the-effects-of-endogenous-cannabinoids/
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner (full–2009) http://cardiovascres.oxfordjournals.org/content/85/1/56.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Changes in the Endocannabinoid System May Give Insight into new and Effective Treatments for Cancer (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791688/?tool=pmcentrez
Endocannabinoids and Their Receptors as Targets for Obesity Therapy (full-2009) http://press.endocrine.org/doi/full/10.1210/en.2009-0046?view=long&pmid=19372200
Endocannabinoid-mediated control of synaptic transmission (full–2009) http://physrev.physiology.org/content/89/1/309.long
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.05948.x/full
Role of endocannabinoid signaling in anxiety and depression (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808114/
Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death (full-2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1742-4658.2008.06765.x/full
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605181/
Neuropathic Pain and Endocannabinoid-Degradation Blockade (full–2009) http://jpet.aspetjournals.org/content/330/3/669.1.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats (full–2009) http://jn.nutrition.org/content/139/8/1495.long
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain (full-2009) http://jpet.aspetjournals.org/content/330/3/902.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system (full–2009) http://stroke.ahajournals.org/content/40/6/2157.long
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716432/?tool=pubmed
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain (full–2009) http://www.molecularpain.com/content/5/1/35
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling (full–2009) http://jpet.aspetjournals.org/content/331/2/591.long
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full–2009) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000100011&lng=en&nrm=iso
The endocannabinoid 2-arachidonoylglycerol promotes sperm developement through activation of cannabinoid-2 receptors (full–2009) http://www.cannabis-med.org/data/pdf/en_2009_04_2_0.pdf
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo (full–2009) http://www.pnas.org/content/106/48/20270.long
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation (full–2009) http://www.nature.com/ijo/journal/v33/n2s/full/ijo200967a.html
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarizationinduced suppression of excitation in autaptic hippocampal neurons (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784730/
Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768754/
From endocannabinoid profiling to ‘endocannabinoid therapeutics’ (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19497779
Circulating endocannabinoid concentrations during orthostatic stress (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19756829
Effects of cannabinoid drugs on the reinforcing properties of food in gestationally
undernourished rats (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19602424
Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by
follicle-stimulating hormone (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19647115
Endocannabinoids: friends and foes of reproduction (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19602425
Skeletal anabolic activity of cannabinoid receptor agonists (abst-2009) http://www.thebonejournal.com/article/S8756-3282%2809%2900121-5/abstract
top


2-AGE / 2-ARACHIDONYL GLYCERYL ETHER / NOLADIN ETHER
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31108/
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages (full–2001) http://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.2001.00413.x/full
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid (full–2002) http://www.iovs.org/content/43/10/3216.full
Endocannabinoid Degradation, Endotoxic Shock and Inflammation (link to PDF–2002) http://www.eurekaselect.com/91915/article
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12384227
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12395075
Endocannabinoids and related fatty acid derivatives in pain modulation (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/11904167
Endocannabinoids in the central nervous system-an overview (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12052038
Synthesis, in vitro evaluation and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/14584958
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors (full–2005) http://jpet.aspetjournals.org/content/314/2/868.long
Role of the endocannabinoid system in the development of tolerance to alcohol (full–2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15763177
Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility (full–2006) http://www.iovs.org/content/47/5/1999.long
2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17292352
The role of the CB1 receptor in the regulation of sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full–2009) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000100011&lng=en&nrm=iso


ANANDAMIDE / AEA / N-ARACHIDONOYLETHANOLAMINE
Phytocannabinoids (news–undated)
http://www.news-medical.net/health/Phytocannabinoids.aspx
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors (full-2000) http://www.jbc.org/content/275/41/31938.full
Endocannabinoids and Vascular Function (full-2000) http://jpet.aspetjournals.org/content/294/1/27.long
Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell
Proliferation (full-2000) http://press.endocrine.org/doi/full/10.1210/endo.141.1.7239?view=long&pmid=10614630
Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human (full-2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1571997/?tool=pmcentrez
Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors (full–2000) http://www.jbc.org/content/275/41/31938.long
Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase (full–2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572338/
Behaviroal, pharmacological, and molecular characterization of an amphibian
cannabinoid receptor (full–2000) http://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.2000.0750413.x/full
Endogenous cannabinoids and appetite (full–2000) http://journals.cambridge.org/download.php?file=%2FNRR%2FNRR14_01%2FS095442240100004Xa.pdf&code=840ac1e121b1a8563a840b894cced959
Cardiovascular effects of endocannabinoids-the plot thickens (abst-2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=10785543&dopt=abstractplus
Bidirectional control of airway responsiveness by endogenous cannabinoids (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11081515
Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10762668
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11106791
Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to
increased brain levels of the corresponding N-acylethanolamines in piglets (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC33480/?tool=pubmed
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts (full–2001) http://cardiovascres.oxfordjournals.org/content/55/3/619.full?sid=750cba66-d3d1-484d-96e8-04975ba34325
Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors (full-2001) http://jpet.aspetjournals.org/content/299/3/951.full
Exogenous anandamide protects rat brain against acute neuronal injury in vivo (full–2001) http://www.jneurosci.org/content/21/22/8765.long
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573067/?tool=pmcentrez
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1222054/pdf/11485574.pdf/?tool=pmcentrez
Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573021/?tool=pmcentrez
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full-2001) http://content.onlinejacc.org/cgi/content/full/38/7/2048?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT
Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular
endothelium, arachidonic acid metabolites and potassium channels (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573033/
Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572613/?tool=pmcentrez
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC55427/?tool=pubmed
Administration of Endocannabinoids Prevents a Referred Hyperalgesia Associated With Inflammation of the Urinary Bladder (full–2001) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1945092&resultClick=3
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages (full–2001) http://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.2001.00413.x/full
The neurobiology and evolution of cannabinoid signalling (full-2001) http://rstb.royalsocietypublishing.org/content/356/1407/381.full.pdf+html
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572815/
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621151/
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572991/
Leptin-regulated endocannabinoids are involved in maintaining food intake (letter–2001) http://www.ncbi.nlm.nih.gov/pubmed/11298451
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic
effects of epinephrine: role of CB(1) and CB(2) receptors (abst-2001) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11427912&dopt=abstractplus
Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11350214
Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11828716
The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11394887
The secret of internal bliss revealed (news–2001) http://www.alphagalileo.org/ViewItem.aspx?ItemId=49926&CultureCode=en
Quantification of anandamide content in animal cells and tissues: the normalization
makes the difference (full-2002) http://www.lipidworld.com/content/1/1/4
Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer (full–2002) http://molehr.oxfordjournals.org/content/8/2/188.full
Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors,
Vanilloid Receptors, and Anandamide (full–2002) http://www.cannabis-med.org/data/pdf/2002-01-3.pdf
Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation (full–2002) http://bloodjournal.hematologylibrary.org/content/100/12/4040.full
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full-2002) http://bloodjournal.hematologylibrary.org/cgi/content/full/100/2/627?ijkey=eb71d6d7a06f311440761cfac6a7d081bcc2771d
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding (full-2002) http://www.jneurosci.org/content/22/21/9612.full
‘Entourage’ effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide
metabolism (full–2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573364/
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission (full–2002) http://www.jneurosci.org/content/22/16/6900.long
Anandamide uptake by synaptosomes from human, mouse and rat brain: inhibition by glutamine and glutamate (full–2002) http://www.lipidworld.com/content/1/1/1
Endocannabinoid Degradation, Endotoxic Shock and Inflammation
(link to PDF–2002) http://www.eurekaselect.com/91915/article
Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism (abst-2002) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12428277&dopt=abstractplus
Endocannabinoids in the central nervous system–an overview (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12052038
Regulation of anandamide tissue levels by N-arachidonylglycine (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12234618
The endocannabinoid system: function in survival of the embryo, the newborn and the
neuron (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12395075
Endocannabinoids and related fatty acid derivatives in pain modulation (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12227101
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12384227
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12393235
N-Acylethanolamines in human reproductive fluids (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505702
Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/11973452
Endocannabinoids in the immune system and cancer (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12052046
The quest for a vascular endothelial cannabinoid receptor (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505689
Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12570018
Role of Endogenous Cannabinoids in Synaptic Signaling (full-2003) http://physrev.physiology.org/cgi/content/full/83/3/1017?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon (full–2003) http://ajpgi.physiology.org/content/286/1/G110.full?sid=fc6948f0 -78cf-405c-981b-afaa05ee417c
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573770/?tool=pmcentrez
Endocannabinoid signalling in the blood of patients with schizophrenia (full–2003) http://www.lipidworld.com/content/2/1/5
A new endothelial target for cannabinoids (full-2003) http://molpharm.aspetjournals.org/content/63/3/469.long
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice (full-2003) http://www.gastrojournal.org/article/S0016-5085%2803%2900892-8/fulltext
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166293/
Endocannabinoids protect the rat isolated heart against ischaemia (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573907/?tool=pmcentrez
Cannabis and the brain (full-2003) http://brain.oxfordjournals.org/cgi/content/full/126/6/1252
Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl
Glycerol, in Rat Brain (full-2003) http://www.nature.com/npp/journal/v28/n6/full/1300117a.html
Manipulation of the endocannabinoid system by a general anaesthetic (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573927/?tool=pubmed
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis (full-2003) http://brain.oxfordjournals.org/cgi/content/full/126/10/2191?ijkey=c7c6bfd158b85c98cb1a190d5ca2614552989ba0
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor (full–2003) http://molpharm.aspetjournals.org/content/63/3/699.long
Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574152/
Therapeutic potential of cannabinoids in CNS disease (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/12617697
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo
microdialysis study (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/14746372?dopt=Abstract
Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12751821
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extrabut not intracellular pH (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12644895
The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal
axis in CB1 cannabinoid receptor knockout mice. (abst – 2003)
http://www.ncbi.nlm.nih.gov/pubmed/14688442?dopt=Abstract
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/12746841?dopt=Abstract
Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12948856
Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716 (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12447606
Novel selective and metabolically stable inhibitors of anandamide cellular uptake (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12732359
The endocannabinoid system: a general view and latest additions (full-2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574255/?tool=pmcentrez
Endocannabinoids: Getting the message across (full-2004) http://www.pnas.org/content/101/23/8512.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=2880&resourcetype=HWCIT
Endocannabinoids and Their Implications for Epilepsy (full-2004) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1176361&tool=pmcentrez
Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception (full-2004) http://jpet.aspetjournals.org/content/309/1/56.full
Endogenous Cannabinoids Take the Edge off Neuroendocrine Responses to Stress
(full–2004) http://press.endocrine.org/doi/full/10.1210/en.2004-1218
The endocannabinoid system: a general view and latest additions (full-2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574255/?tool=pmcentrez
The complexities of the cardiovascular actions of cannabinoids (full-2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574918/?tool=pmcentrez
The endocannabinoid system: physiology and pharmacology (full-2004) http://alcalc.oxfordjournals.org/cgi/content/full/40/1/2
Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(_)-MethanandamideInduced Apoptotic Death of Human Neuroglioma Cells (full-2004) http://molpharm.aspetjournals.org/content/66/6/1643.full.pdf+html
Involvement of cannabinoid receptors in gut motility and visceral perception (full-2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/?tool=pmcentrez
Plasma Levels of the Endocannabinoid Anandamide in Women—A Potential Role in Pregnancy Maintenance and Labor? (full-2004)
http://press.endocrine.org/doi/full/10.1210/jc.2004-0681?view=long&pmid=15531501
A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2
Secretion in Murine Splenocytes (full–2004) http://jpet.aspetjournals.org/content/311/2/683.full
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes (full-2004) http://ajpgi.physiology.org/content/291/2/G364
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172 (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC423268/
The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation (full–2004) http://ar.iiarjournals.org/content/28/6A/3743.long
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus (full–2004) http://molehr.oxfordjournals.org/content/10/4/215.full
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574972/
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1 (abst-2004) http://www.sciencedirect.com/science/article/pii/S0090825803009521
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14744610
A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14715265
Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14672756
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14676677
Exercise activates the endocannabinoid system (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14625449
How our brains fend off madness, we produce a cannabis like substance (news–2004) http://www.medicalnewstoday.com/releases/12516.php
Easing anxiety with anandamide (news–2004) http://www.rsc.org/chemistryworld/Issues/2004/July/anandamide.asp
Study links marijuana buzz to ‘runner’s high’ (news–2004) http://www.cnn.com/2004/HEALTH/01/11/marijuana.exercise.reut/
Study: Exercise Produces Cannabinoids (news–2004) http://www.drugfree.org/join-together/drugs/study-exercise-produces
Cardiovascular Pharmacology of Cannabinoids (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228270/?tool=pmcentrez
The cardiovascular actions of anandamide: more targets? (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576182/?tool=pmcentrez
Role of the endocannabinoid system in the development of tolerance to alcohol (full–2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
Cannabinoids promote hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects (full-2005) http://www.jci.org/cgi/content/full/115/11/3104
Cannabinoids and cancer: potential for colorectal cancer therapy (full-2005) http://www.biochemsoctrans.org/bst/033/0712/bst0330712.htm
Antidepressant-like Activity and Modulation of Brain Monoaminergic Transmission by Blockade of Anandamide Hydrolysis (full–2005) http://www.pnas.org/content/102/51/18620.long
Blood pressure regulation by endocannabinoids and their receptors (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225528/?tool=pmcentrez
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774787/?tool=pmcentrez
The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576168/?tool=pmcentrez
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanism (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751211/?tool=pmcentrez
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161/?tool=pmcentrez
Antidepressant-like activity by blockade of anandamide hydrolysis (full-2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16352709
Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa (full–2005) http://www.nature.com/npp/journal/v30/n6/full/1300695a.html
Analgesia through endogenous cannabinoids (full-2005) http://www.cmaj.ca/cgi/content/full/173/4/357?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=endocannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors (full–2005) http://gut.bmj.com/content/54/4/522.full?sid=0731f0e5-2071-4549-be57-57f444307138
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity (full–2005) http://www.jlr.org/content/46/2/342.long
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma (full–2005) http://www.sciencedirect.com/science/article/pii/S0014579305013803
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility (full–2005) http://molehr.oxfordjournals.org/content/11/1/21.full
Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity (full–2005) http://www.jneurosci.org/content/25/34/7813.long
Chocolate and cannabis (article–2005) http://www.cannabisculture.com/content/2005/05/09/4337
Cannabinoids and the digestive tract (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16596788
Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and Narachidonoyldopamine (NADA) in the rat isolated aorta (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15659311
Targeted lipidomics: fatty acid amides and pain modulation (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16099389
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus (abst–2005) http://www.sciencedirect.com/science/article/pii/S0028390805001668
Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15923084
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
Influence of Anandamide, the Endogenous Agonist of Cannabinoid Receptors on the Circulatory System (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/15928605
Finding of endocannabinoids in human eye tissues: implications for glaucoma (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15823551
Anandamide transport: a critical review (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15979096
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16022863
Waterborne lead exposure affects brain endocannabinoid content in male but not female fathead minnows (Pimephales promelas) (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15527869
Anandamide Compound Targets Brain’s ‘Bliss’ System (news–2005) http://alcoholism.about.com/od/cure/a/blnida050112.htm
Anandamide in Chocolate (news–2005) http://www.herbmuseum.ca/content/anandamide-chocolate
A biosynthetic pathway for anandamide (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557387/
Activation of G-proteins in brain by endogenous and exogenous cannabinoids (full–2006) http://www.ncbi.nlm.nih.gov/pubmed/16584117
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia (full-2006) http://press.endocrine.org/doi/full/10.1210/jc.2005-2679?view=long&pmid=16684820
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856307/
Endocannabinoids, feeding and suckling – from our perspective (full–2006) http://www.nature.com/ijo/journal/v30/n1s/full/0803274a.html
Stage-variations of anandamide hydrolase activity in the mouse uterus during the natural oestrus cycle (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440866/?tool=pubmed
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice (full-2006) http://www.fasebj.org/cgi/content/full/20/7/1003
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation (full–2006) http://www.fasebj.org/content/early/2006/03/01/fj.05-4943fje.long
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458883/?tool=pmcentrez
Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor mediated excitotoxic damage (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751782/?tool=pmcentrez
Not Too Excited? Thank Your Endocannabinoids (full-2006) http://www.sciencedirect.com/science/article/pii/S0896627306005927
Effect of N-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter inhibitor, on capsaicin-induced cough in mice (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448189/?tool=pmcentrez
Effects of general anesthesia on anandamide blood levels in humans (full–2006) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1923152&resultClick=3
Cannabinoids and the Endocannabinoid System (full-2006) http://www.cannabis-med.org/english/journal/en_2006_01_2.pdf
Is there a temperature-dependent uptake of anandamide into cells? (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1629410/
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation (full–2006) http://www.fasebj.org/content/early/2004/10/02/fj.04-1754fje.long
Cannabinoids in acute gastric damage and pancreatitis (full–2006) http://www.jpp.krakow.pl/journal/archive/11_06_s5/pdf/137_11_06_s5_article.pdf
Anxiolytic-like properties of the anandamide transport inhibitor AM404 (full–2006) http://www.nature.com/npp/journal/v31/n12/full/1301061a.html
EFFECT OF CANNABINOIDS ON TESTICULAR ISCHEMIA-REPERFUSION INJURY IN RAT (full–2006) http://journals.tums.ac.ir/upload_files/pdf/_/3279.pdf
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells (full–2006) http://www.sciencedirect.com/science/article/pii/S0896627305010081
Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition (full–2006) http://www.sciencedirect.com/science/article/pii/S0014579305015644
Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations (full–2006) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2006.04104.x/full
Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors (full-forum repost-2006) http://www.420magazine.com/forums/am-251/142301-inhibition-salivary-secretion-activationcannabinoid-receptors.html
Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16506408
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16949718
Role of cannabinoid receptor agonists in mechanisms of suppression of central pain syndrome (abst-2006) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=17369898&dopt=abstractplus
Anandamide inhibits adhesion and migration of breast cancer cells (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16343481?dopt=Abstract
Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17027744
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16442133
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16480822
Endocannabinoid Degradation and Oxidative Defense Mechanisms Determine Anandamide-induced Cell Death in Liver Cell Populations (abst–2006) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2006-931661
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16480822
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16732431
Release of anandamide from blood cells (abst–2006) http://www.degruyter.com/abstract/j/cclm.2006.44.issue-4/cclm.2006.065/cclm.2006.065.xml?rskey=jSEJyD&result=7&q=cannabinoid
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington’s disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16006105
Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16787257
Metabolism of Anandamide an Endogenous Cannabinoid (chart–2006) http://pid.nci.nih.gov/search/pathway_landing.shtml?source=BioCarta%20Imported&what=graphic&jpg=on&ppage=1&pathway_id=cb1rpathway
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190014/?tool=pubmed
The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport (full-2007) http://jpet.aspetjournals.org/content/321/1/370.full
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2083705/?tool=pubmed
Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner (full–2007) http://www.jbc.org/content/283/10/6005.full?sid=931583b1-e797-43e0-8296-7fd75bb49403#sec-4
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson’s disease: role of CB1 and TRPV1 receptors (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128772/?tool=pmcentrez
Regulation of brain anandamide by acute administration of ethanol (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868843/
Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ‘liking’ of a sweet reward (full–2007) http://www.nature.com/npp/journal/v32/n11/full/1301376a.html
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage (full–2007) http://jpet.aspetjournals.org/content/322/3/1059.long
Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms (full-2007) http://journals.tums.ac.ir/upload_files/pdf/_/6670.pdf
Identification of Endocannabinoids and Related Compounds in Human Fat Cells (full-2007) http://onlinelibrary.wiley.com/doi/10.1038/oby.2007.581/full
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190006/?tool=pmcentrez
Endocannabinoids and the haematological system (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez
Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190007/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis (full-2007) http://www.jbc.org/content/282/33/23892.full
The orphan receptor GPR55 is a novel cannabinoid receptor (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095107/?tool=pubmed
Chronologically overlapping occurrences of nicotine-induced anxiety- and depression related behavioral symptoms: effects of anxiolytic and cannabinoid drugs (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075518/?tool=pubmed
Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced Ischemia in Rats (full-2007) http://www.iovs.org/cgi/content/full/48/7/2997?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation (full–2007) http://ajpgi.physiology.org/content/294/2/G506.full
Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth (full-2007) http://www.jbc.org/content/282/17/13098.full
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice (full–2007) http://jpet.aspetjournals.org/content/322/1/236.long
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225473/?tool=pubmed
STUDIES OF ANANDAMIDE ACCUMULATION INHIBITORS IN CEREBELLAR GRANULE NEURONS (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248273/
Anandamide-Mediated CB1/CB2 Cannabinoid Receptor-Independent Nitric Oxide Production in Rabbit Aortic Endothelial Cells (full–2007) http://jpet.aspetjournals.org/content/321/3/930.long
n-3 Fatty acids and the endocannabinoid system (letter–2007) http://ajcn.nutrition.org/content/85/3/919.1.long
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher (interview-2007) http://www.jleukbio.org/cgi/content/full/82/6/1390?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17921818
Fatty acid amide hydrolase: from characterization to therapeutics (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17712824
The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17706636
Effect of Endocannabinoid System on the Neurogenic Function of Rat Corpus Cavernosum (abst–2007) http://rjms.iums.ac.ir/browse.php?a_code=A-10-1-760&sid=1&slc_lang=en
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients (abst-2007) http://www.unboundmedicine.com/medline/ebm/record/17566707/abstract/Anandamide_levels_in_cerebrospinal_fluid_of_first_episode_schizophrenic_patients:_Impact_of_cannabis_use
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumorsuppressor efficacy (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17192847
Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17222495
Attenuation of allergic contact dermatitis through the endocannabinoid system (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17556587
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17511970
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17459108
Endocannabinoid system in cancer cachexia (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17563462
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17931597
Characterization of cannabinoid-binding sites in zebrafish brain (abst–2007) http://www.frontiersin.org/publications/17178193
Marijuana-Like Brain Chemicals Work As Antidepressant (news-2007) http://www.sciencedaily.com/releases/2007/11/071105120556.htm
Role seen for cannabis in helping to alleviate allergic skin disease (news-2007) http://www.physorg.com/news106487623.html
The Endocannabinoids: Functional Roles and Therapeutic Opportunities (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11344&CultureCode=en
Health Benefits of Chocolate (news–2007) http://chocolate.org/health/chocprescribe.html
CB1 Cannabinoid Receptor Inhibition: Promising Approach for Heart Failure? (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669829/?tool=pmcentrez
A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain (full–2008) http://www.jneurosci.org/content/28/44/11141.long
N-arachidonylethanolamide-Induced Increase in Aqueous Humor Outflow Facility (full-2008) http://www.iovs.org/cgi/content/full/49/10/4528
Expression of the Endocannabinoid System in Human First Trimester Placenta and Its
Role in Trophoblast Proliferation (full–2008) http://endo.endojournals.org/content/149/10/5052.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597234/
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin Induced Cardiotoxicity (full-2008) http://content.onlinejacc.org/cgi/content/full/50/6/528
Degradation of endocannabinoids in chronic migraine and medication overuse headache (full-2008) http://www.hsantalucia.it/san/attscien2008/I%20pagine%20pubblicazioni/Degradation%20of%20endocannabinoids%20in%20chronic%20migraine%20and%20medication%20overuse%20headache.pdf
Role of endocannabinoids in cardiovascular shock (full–2008) http://www.jpp.krakow.pl/journal/archive/12_08_s8/pdf/91_12_08_s8_article.pdf
Modulation of the Endocannabinoid System in Cardiovascular Disease (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568884/?tool=pmcentrez
Cannabinoid receptors and the regulation of bone mass (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219540/?tool=pmcentrez
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01674.x/full
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697765/?tool=pmcentrez
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells (full-2008) http://molpharm.aspetjournals.org/content/74/1/20.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block
Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide (full–2008) http://www.jpp.krakow.pl/journal/archive/12_08/pdf/673_12_08_article.pdf
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages (full–2008) http://cardiovascres.oxfordjournals.org/content/81/4/805.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Gastrointestinal Regulation of Food Intake: General Aspects and Focus on Anandamide and Oleoylethanolamide (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01686.x/full
Endocannabinoids in the retina: from marijuana to neuroprotection (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584875/
Endocannabinoids and the Control of Energy Homeostasis (full–2008) http://www.jbc.org/content/283/48/33021.full?sid=931583b1-e797-43e0-8296-7fd75bb49403
Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion (full–2008) http://joe.endocrinology-journals.org/content/199/2/235.long
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604798/?tool=pmcentrez
The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway (full–2008) http://erc.endocrinology-journals.org/cgi/content/full/15/4/965
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling (full–2008) http://www.fasebj.org/content/22/10/3685.long
Role of cannabinoids and endocannabinoids in cerebral ischemia (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581413/?tool=pmcentrez
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2 (full–2008) http://molpharm.aspetjournals.org/content/73/2/441.long
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full-2008) http://onlinelibrary.wiley.com/doi/10.1038/oby.2007.106/pdf
Activation of the endocannabinoid system by organophosphorus nerve agents (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597283/
Mechanisms for Recycling and Biosynthesis of Endogenous Cannabinoids Anandamide and 2-Arachidonylglycerol (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581634/?tool=pmcentrez
Inhibition of anandamide hydrolysis by URB597 reverses abuse-related behavior and neurochemical effects of nicotine in rats (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663803/?tool=pubmed
Endocannabinoids and nutrition (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full
Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01684.x/full
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (full–2008) http://proxy.baremetal.com/cannabiscoalition.ca/info/Russo_Clinical_Endocannabin.pdf
Endogenous cannabinoids: structure and metabolism (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01676.x/full
Cannabinoid Receptors in Conjunctival Epithelium: Identification and Functional Properties (full–2008) http://iovs.arvojournals.org/article.aspx?articleid=2125015&resultClick=1
Evidence for the intracellular accumulation of anandamide in adiposomes (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18213445/
Role of endocannabinoids and their analogues in obesity and eating disorders (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19011363
The endocannabinoid system: emotion, learning and addiction (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18422832
Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18593574
Anandamide and neutrophil function in patients with fibromyalgia (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18395993
Anandamide effects on 5-HT(3) receptors in vivo (abst–2008) http://www.frontiersin.org/publications/18775693
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18204441
Pro-drugs for indirect cannabinoids as therapeutic agents (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18855592
The role of the CB1 receptor in the regulation of sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18823959
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18535023
Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18289091
Effect of anandamide in improving of the non-adrenergic non-cholinergic relaxation of the corpus cavernosum from diabetic rats (abst–2008) http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-553&slc_lang=en&sid=1&sw=choline
Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18234188
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18343566
The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and antihyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18602217
Cannabinoids in the control of pain (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19388223
Understanding the effects of endogenous cannabinoids (news-2008) http://arstechnica.com/science/news/2008/11/understanding-the-effects-of-endogenous-cannabinoids.ars
Marijuana-Inspired Painkiller? New Chemical Pathway Discovered (news-2008) http://www.sciencedaily.com/releases/2008/11/081123150249.htm
Understanding the Effects of Endogenous Cannabinoids (news–2008) http://arstechnica.com/science/2008/11/understanding-the-effects-of-endogenous-cannabinoids/
Endocannabinoids and the Heart (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728560/?tool=pmcentrez
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/?tool=pmcentrez
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716432/?tool=pubmed
Localisation and Function of the Endocannabinoid System in the Human Ovary (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640464/?tool=pmcentrez
Changes in the Endocannabinoid System May Give Insight into new and Effective Treatments for Cancer (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791688/?tool=pmcentrez
The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757501/
Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death (full-2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1742-4658.2008.06765.x/full
Endogenous cannabinoids induce fever through the activation of CB1 receptors (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765314/?tool=pubmed
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo (full–2009) http://www.pnas.org/content/106/48/20270.long
Neuropathic Pain and Endocannabinoid-Degradation Blockade (full–2009) http://jpet.aspetjournals.org/content/330/3/669.1.full?sid=af53ea87 -ab4b-426e-9c7e-8f750e9c4a17
Biomarkers of Endocannabinoid System Activation in Severe Obesity (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808340/?tool=pubmed
Endocannabinoids and Their Receptors as Targets for Obesity Therapy (full-2009) http://press.endocrine.org/doi/full/10.1210/en.2009 -0046?view=long&pmid=19372200
The endocannabinoid system in bull sperm and bovine oviductal epithelium: role of anandamide in sperm-oviduct interaction (full-2009) http://www.reproduction-online.org/cgi/content/full/137/3/403
Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation (full–2009) http://humrep.oxfordjournals.org/content/24/8/1989.long
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1601-183X.2009.00518.x/full
Role of endocannabinoid signaling in anxiety and depression (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808114/
Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development (full–2009) http://www.rbej.com/content/7/1/121
Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739820/?tool=pubmed
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.05948.x/full
The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689249/?tool=pubmed
Characterization of the Endocannabinoid System in Human Neuronal Cells and Proteomic Analysis of Anandamide-induced Apoptosis (full–2009) http://www.jbc.org/content/284/43/29413.full
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner (full–2009) http://cardiovascres.oxfordjournals.org/content/85/1/56.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats (full–2009) http://jn.nutrition.org/content/139/8/1495.long
Endocannabinoid-mediated control of synaptic transmission (full–2009) http://physrev.physiology.org/content/89/1/309.long
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757605/?tool=pubmed
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain (full-2009) http://jpet.aspetjournals.org/content/330/3/902.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain (full–2009) http://www.molecularpain.com/content/5/1/35
Receptors for acylethanolamides-GPR55 and GPR119 (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed
Anandamide injected into the lateral ventricle of the brain inhibits submandibular salivary secretion by attenuating parasympathetic neurotransmission (full–2009) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000600010&lng=en&nrm=iso
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full–2009) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000100011&lng=en&nrm=iso
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation (full–2009) http://www.nature.com/ijo/journal/v33/n2s/full/ijo200967a.html
Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system (full–2009) http://stroke.ahajournals.org/content/40/6/2157.long
ALTERED ANANDAMIDE DEGRADATION IN ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (full–2009) http://www.neurology.org/content/72/17/1526.long
Opposite effects of anandamide and n-arachidonoyl dopamine in the regulation of prostaglandin E2 and 8-iso-PGF2α formation in primary glial cells (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.05966.x/full
Endocannabinoids and reproductive biology (letter-2009) http://humrep.oxfordjournals.org/content/24/7/1771.full.pdf+html
The Endocannabinoid Anandamide: From Immunomodulation to Neuroprotection. Implications for Multiple Sclerosis (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19647114
From endocannabinoid profiling to ‘endocannabinoid therapeutics’ (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19497779
Plasma endocannabinoid levels in multiple sclerosis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19695579
Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19647115
Enhanced anandamide plasma levels in patients with complex regional pain syndrome following traumatic injury: a preliminary report (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19729930
Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19580839
Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19394652
Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19399401
Circulating endocannabinoid concentrations during orthostatic stress (abst–2009) www.ncbi.nlm.nih.gov/pubmed/19756829
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis (abst-2009) http://www.unboundmedicaine.com/medline/ebm/record/19189054/abstract/A_metabolically_stable_analogue_of_anandamide_Met_F_AEA_inhibits_human_thyroid_carcinoma_cell_lines_by_activation_of_apoptosis_
Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19409856
Is GPR55 an anandamide receptor? (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19647110
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/17397826
Endocannabinoids: friends and foes of reproduction (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19602425
Cannabinoid in the nucleus accumbens enhances the intake of palatable solution (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19734811
N-acylethanolamines, anandamide and food intake (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19413995
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19095868
Sleep-inducing factors (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19689305
Skeletal anabolic activity of cannabinoid receptor agonists (abst-2009) http://www.thebonejournal.com/article/S8756-3282%2809%2900121-5/abstract
Endocannabinoids prevent lysosomal membrane destabilisation evoked by treatment with β-amyloid in cultured rat cortical neurons (abst-forum repost–2009) http://forum.grasscity.com/medical-marijuana-usage-applications/1029121-alzheimersstudy.html#post14325992
top